Consensus and controversies in platelet transfusion: Trigger for indication, and platelet dose

Transfusion Clinique et Biologique

Volumn 14, Issue 6, 2007, Pages 504-508

  Lozano, M ^a   Cid, J ^b  

^a INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^b HOSPITAL UNIVERSITARI JOAN XXIII   (Spain)

Author keywords

Platelet dose; Platelet transfusion; Prophylactic platelet transfusion

Indexed keywords

APHERESIS; ARTICLE; BLEEDING; CLINICAL TRIAL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; LEUKEMIA; PATIENT CARE; PROPHYLAXIS; THROMBOCYTE COUNT; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA; WORLD HEALTH ORGANIZATION;

CONSENSUS; HEMORRHAGE; HUMANS; PLATELET TRANSFUSION;

EID: 43049142582     PISSN: 12467820     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tracli.2008.03.002     Document Type: Article

References (28)

1. Freireich E.J. Supportive care for patients with blood disorders. Br J Haematol 111 (2000) 68-77
2. Djerassi I., Farber S., and Evans A.E. Transfusion of fresh platelet concentrates to patients with secondary thrombocytopenia. N Engl J Med 268 (1963) 221-226
3. Gaydos L.A., Freireich E.J., and Mantel N. The quantitative relation between platelet count and hemorrhage in patients with acute leukemia. N Engl J Med 266 (1962) 905-909
4. Aggeler P.M., Howard J., and Lucia S.P. Platelet counts and platelet function. Blood 1 (1946) 472-496
5. Slichter S.J., and Harker L.A. Thrombocytopenia: mechanisms and management of defects in platelet production. Clin Haematol 7 (1978) 523-539
6. Hanson S.R., and Slichter S.J. Platelet kinetics in patients with bone marrow hypoplasia: evidence for a fixed platelet requirement. Blood 66 (1985) 1105-1109
7. Gmür J., Burger J., Schanz U., Fehr J., and Schaffner A. Safety of stringent prophylactic platelet transfusion policy for patients with acute leukaemia. Lancet 338 (1991) 1223-1226
8. Heckman K.D., Weiner G.J., Davis C.S., Strauss R.G., Jones M.P., and Burns C.P. Randomized study of prophylactic platelet transfusion threshold during induction therapy for adult acute leukemia: 10,000/μL versus 20,000/μL. J Clin Oncol 15 (1997) 1143-1149
9. Rebulla P., Finazzi G., Marangoni F., Avvisati G., Gugliotta L., Tognoni G., et al. The threshold for prophylactic platelet transfusions in adults with acute myeloid leukemia. Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto. N Engl J Med 337 (1997) 1870-1875
10. Navarro J.T., Hernandez J.A., Ribera J.M., Sancho J.M., Oriol A., Pujol M., et al. Prophylactic platelet transfusion threshold during therapy for adult acute myeloid leukemia: 10,000/μL versus 20,000/μL. Haematologica 83 (1998) 998-1000
11. 9/L trigger: a prospective comparative trial in 105 patients with acute myeloid leukemia. Blood 91 (1998) 3601-3606
12. Gil Fernández J.J., Alegre A., Fernandez-Villalta M.J., Pinilla I., Gomez Garcia V., Martinez C., et al. Clinical results of a stringent policy on prophylactic platelet transfusion: non-randomized comparative analysis in 190 bone marrow transplant patients from a single institution. Bone Marrow Transplant 18 (1996) 931-935
13. Lawrence J.B., Yomtovian R.A., Hammons T., Masarik S.R., Chongkolwatana V., Creger R.J., et al. Lowering the prophylactic platelet transfusion threshold: a prospective analysis. Leuk Lymphoma 41 (2001) 67-76
14. 9 per L. Transfusion 47 (2007) 801-812
15. Zumberg M.S., del Rosario M.L., Nejame C.F., Pollock B.H., Garzarella L., Kao K.J., et al. A prospective randomized trial of prophylactic platelet transfusion and bleeding incidence in hematopoietic stem cell transplant recipients: 10,000/μL versus 20,000/μL trigger. Biol Blood Marrow Transplant 8 (2002) 569-576
16. 9 per L in allogeneic hematopoietic progenitor cell transplant recipients. Transfusion 45 (2005) 1064-1072
17. 9 per L. Transfusion 47 (2007) 1700-1709
18. Schiffer C.A., Anderson K.C., Bennett C.L., Bernstein S., Elting L.S., Goldsmith M., et al. Platelet transfusion for patients with cancer: Clinical practice guidelines of the American Society of Clinical Oncology. J Clin Oncol 19 (2001) 1519-1538
19. British Committee for Standards in Haematology. Guidelines for the use of platelet transfusions. Br J Haematol 2003;122:10-23.
20. NIH Consensus conference on platelet transfusion therapy. JAMA 1987;257:1777-80.
21. Samama C.M., Djoudi R., Lecompte T., Nathan-Denizot N., and Schved J.F. Perioperative platelet transfusion: recommendations of the Agence Francaise de Securite Sanitaire des Produits de Sante (AFSSaPS)2003. Can J Anaesth 52 (2005) 30-37
22. Norol F., Bierling P., Roudotthoraval F., LeCoeur F.F., Rieux C., Lavaux A., et al. Platelet transfusion: a dose-response study. Blood 92 (1998) 1448-1453
23. Klumpp T.R., Herman J.H., Gaughan J.P., Russo R.R., Christman R.A., Goldberg S.L., et al. Clinical consequences of alterations in platelet transfusion dose: a prospective, randomized, double-blind trial. Transfusion 39 (1999) 674-681
24. Goodnough L.T., Kuter D.J., McCullough J., Slichter S.J., DiPersio J., Romo J., et al. Prophylactic platelet transfusions from healthy apheresis platelet donors undergoing treatment with thrombopoietin. Blood 98 (2001) 1346-1351
25. Tinmouth A., Tannock I.F., Crump M., Tomlinson G., Brandwein J., Minden M., et al. Low-dose prophylactic platelet transfusions in recipients of an autologous peripheral blood progenitor cell transplant and patients with acute leukemia: a randomized controlled trial with a sequential Bayesian design. Transfusion 44 (2004) 1711-1719
26. Sensebe L., Giraudeau B., Bardiaux L., Deconinck E., Schmidt A., Bidet M.L., et al. The efficiency of transfusing high doses of platelets in hematologic patients with thrombocytopenia: results of a prospective, randomized, open, blinded end point (PROBE) study. Blood 105 (2005) 862-864
27. Cid J., and Lozano M. Lower or higher doses for prophylactic platelet transfusions: results of a meta-analysis of randomized controlled trials. Transfusion 47 (2007) 464-470
28. Slichter S.J. Background, rationale, and design of a clinical trial to assess the effects of platelet dose on bleeding risk in thrombocytopenic patients. J Clin Apheresis 21 (2006) 78-84